CTNI-09. VORASIDENIB AS MAINTENANCE TREATMENT AFTER FIRST-LINE CHEMORADIOTHERAPY IN IDH-MUTANT GRADE 2/3 ASTROCYTOMA: STUDY PROTOCOL FOR THE PLACEBO-CONTROLLED, TRIPLE-BLIND, RANDOMIZED PHASE III STUDY EORTC-2427 (VIGOR)
CTNI-09. 沃拉西地尼作为一线放化疗后IDH突变2/3级星形细胞瘤的维持治疗:安慰剂对照、三盲、随机III期研究EORTC-2427(VIGOR)的研究方案
期刊:
影响因子:
doi:10.1128/genomeA.01450-14
Cabezas-Cruz, Alejandro; Zweygarth, Erich; Broniszweska, Marzena; Passos, Lygia M F; Ribeiro, Múcio Flávio Barbosa; Manrique, Marina; Tobes, Raquel; de la Fuente, José; Geurts, Marjolein; LeRhun, Emilie; Minniti, Giuseppe; Padovan, Marta; Duerinck, Johnny; Franceschi, Enrico; Touat, Mehdi; Pace, Andrea; Sahm, Felix; Furtner, Julia; Albert, Nathalie; Lohman, Philipp; van Zandvoort, Martine; Quoilin, Caroline; Daumer, Corinne; Koh, Eng-Siew; Pitz, Marshall; Gorlia, Thierry; Weller, Michael; van den Bent, Martin; Preusser, Matthias